AFG2B
protein-codingAFG2 AAA ATPase homolog B, the group of AAA ATPases
Gene summary
Enables identical protein binding activity and preribosome binding activity. Involved in DNA replication; regulation of ribosome biogenesis; and ribosomal large subunit biogenesis. Located in cytoplasm; nucleus; and spindle. Implicated in autosomal recessive nonsyndromic deafness. [provided by Alliance of Genome Resources, Jun 2026]
- SPATA5L1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~19.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0030480
Submitter: ClinGen
AFG2B/SPATA5L1 was first reported in relation to autosomal recessive deafness 119 (DFNB119) in 2021 (Richard et al.; PMID: 34626583). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found clear differences in phenotypic variability. Therefore, the following disease entities have been split into two disease entities, DFNB119 (OMIM: 619615) and autosomal recessive neurodevelopmental disorder with hearing loss and spasticity (NEDHLS; OMIM: 619616). The split curation for NEDHLS has been done separately. 4 variants (missense, frameshift) that have been reported in over 20 probands in one publication (PMID: 34626583) are included in this curation. The mechanism of pathogenicity appears to be loss-of-function. This gene-disease relationship is also supported by expression-level evidence (PMID: 34626583; GTEx expression data). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role of AFG2B/SPATA5L1 in isolated hearing loss, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Hearing Loss GCEP on the meeting date 2/21/2024 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0859206
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0030480
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0859206
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0030480
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0859206
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to AFG2B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_024063.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 10 | 13 | |||
| missense | 1 | 13 | 124 | 6 | 2 | 146 |
| nonsense | 1 | 1 | 1 | 3 | ||
| start loss | 1 | 1 | ||||
| frameshift | 4 | 2 | 6 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 7 | 16 | 130 | 16 | 2 | 171 |
Highest pathogenic variant AF is 0.0014405289
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_076968.2 | 8 | MANE Select | |
| Ensembl | ENSP00000305494.6 | 8 | MANE Select | |
| RefSeq | NP_001310569.1 | 5 | Standard | |
| Ensembl | ENSP00000453091.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Molecular Function
- ATP binding
- ATPase activity
Cellular Component
- cytoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000305560
- Coding exons
- 8
- Length
- 19089
- Individuals with no LoFs
- 125636
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 112
- Defined
- 125748
- p
- 0.000445
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.861 | 346 | 394 | 0.878 | 0.0000190 | 4685 |
| Missense (PolyPhen) | 94 | 115.98 | 0.81051 | 1376 | ||
| Synonymous | 0.480 | 162 | 170 | 0.953 | 0.00000872 | 1691 |
| Loss of Function | 1.28 | 20 | 27.2 | 0.735 | 0.00000158 | 303 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00044 | 0.00043 | rare |
| Latino/Admixed American | 0.00053 | 0.00052 | rare |
| Ashkenazi Jewish | 0.00099 | 0.00099 | rare |
| East Asian | 0.00099 | 0.00098 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00041 | 0.00040 | rare |
| South Asian | 0.00027 | 0.00026 | rare |
| Other | 0.00082 | 0.00081 | rare |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.0896
Intolerance Scores
- LoFtool
- 0.211
- RVIS EVS
- -0.22
- RVIS percentile EVS
- 37.54
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- N
- Indispensability score
- 0.200
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | Medium | Medium |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |